BioSpace News Archive

Satsuma Pharmaceuticals, Inc. (Nasdaq: STSA), a clinical-stage biopharmaceutical company, today announced the appointment of Rob Janosky to the newly created position of Chief Commercial Officer.

The Joint Corp. (NASDAQ: JYNT), a national operator, manager and franchisor of chiropractic clinics, reported its financial results for the fourth quarter and full year ended December 31, 2019.

Diversicare Healthcare Services, Inc. (OTCQX: DVCR), a premier provider of long-term care services, today announced its results for the fourth quarter ended December 31, 2019.

The US Drug Watchdog says, “Five weeks ago a medical director at a top 50 US Metro Area hospital called us to tell us that surgical masks in his city were in short supply.

INmune Bio , Inc., an immunology company developing treatments that harness the patient’s innate immune system to fight disease, today announced that management will present at the 32nd Annual Roth Conference at 8:30 a.m. (PT) on Tuesday, March 17, 2020

Cognoa announced that renowned pediatrician and 2018 Past President of the American Academy of Pediatrics, Dr. Colleen Kraft, has joined the company as Senior Medical Director of Clinical Adoption.

Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that the European Patent Office has issued European Patent EP3094318B1

Additional Series B funding comes as Ordr expands to meet growing demand from all industries for their enterprise IoT and unmanaged device security technology

Products become the first and only indicated to reduce blood culture contamination

Molecular diagnostics company XCR Diagnostics has been awarded a patent by the United States Patent and Trademark Office for its technology that speeds up the testing and identification process for infectious diseases.